ImmuneOncia Therapeutics Statistics

Total Valuation

KOSDAQ:424870 has a market cap or net worth of KRW 817.30 billion. The enterprise value is 785.72 billion.

Market Cap	817.30B
Enterprise Value	785.72B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:424870 has 74.17 million shares outstanding. The number of shares has increased by 27.54% in one year.

Current Share Class	74.17M
Shares Outstanding	74.17M
Shares Change (YoY)	+27.54%
Shares Change (QoQ)	+37.47%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	20.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1,141.88
PB Ratio	21.62
P/TBV Ratio	24.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-38.29
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-42.17

Financial Position

The company has a current ratio of 8.18, with a Debt / Equity ratio of 0.00.

Current Ratio	8.18
Quick Ratio	7.36
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.00
Interest Coverage	-3,821.17

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-55.27%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	6,843.60
200-Day Moving Average	n/a
Relative Strength Index (RSI)	73.69
Average Volume (20 Days)	13,073,725

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:424870 had revenue of KRW 715.75 million and -20.52 billion in losses. Loss per share was -306.75.

Revenue	715.75M
Gross Profit	703.19M
Operating Income	-21.13B
Pretax Income	-20.52B
Net Income	-20.52B
EBITDA	-20.21B
EBIT	-21.13B
Loss Per Share	-306.75

Full Income Statement

Balance Sheet

The company has 31.66 billion in cash and 83.14 million in debt, giving a net cash position of 31.58 billion or 425.76 per share.

Cash & Cash Equivalents	31.66B
Total Debt	83.14M
Net Cash	31.58B
Net Cash Per Share	425.76
Equity (Book Value)	37.80B
Book Value Per Share	510.20
Working Capital	31.66B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -18.58 billion and capital expenditures -48.58 million, giving a free cash flow of -18.63 billion.

Operating Cash Flow	-18.58B
Capital Expenditures	-48.58M
Free Cash Flow	-18.63B
FCF Per Share	-251.22

Full Cash Flow Statement

Margins

Gross Margin	98.25%
Operating Margin	-2,952.31%
Pretax Margin	-2,866.97%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KOSDAQ:424870 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.54%
Shareholder Yield	-27.54%
Earnings Yield	-2.51%
FCF Yield	-2.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:424870 has an Altman Z-Score of 46.15 and a Piotroski F-Score of 3.

Altman Z-Score	46.15
Piotroski F-Score	3